Medical imaging solutions provider Qure.ai said on Wednesday it has received clearance from a US health regulator for its artificial intelligence-enabled X-ray for the detection of lung nodules. Qure's chest X-ray-based qXR-LN uses artificial intelligence (AI) to identify and localize lung nodules, thereby helping in identifying potentially malignant pulmonary nodules and thus boosting the fight against lung cancer, the company said in a statement. This also marks the 6th USFDA clearance for Qure's chest X-ray-based solutions, the company said. The qXR for lung nodules is cutting-edge detection software designed to identify and highlight regions indicative of suspected pulmonary nodules ranging from 6 to 30 mm in size. Prashant Warier, co-founder and CEO of Qure.ai, said the company has already deployed and implemented this solution globally, and the USFDA clearance "marks yet another ground-breaking leap in our pioneering efforts to combat lung cancer."